Janus Henderson Group plc 13D and 13G filings for ARCA biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-05 5:20 pm Purchase |
2024-07-02 | 13G | ARCA biopharma, Inc. ABIO |
JANUS HENDERSON GROUP PLC JHG |
123,545 10.200% |
33,536 (+37.26%) |
Filing |
| 2024-04-11 09:51 am Purchase |
2024-04-03 | 13G | ARCA biopharma, Inc. ABIO |
JANUS HENDERSON GROUP PLC JHG |
90,009 7.400% |
90,009 (New Position) |
Filing |